Culture systems that model host-pathogen interactions in the vaginal mucosal epithelium have certain limitations in accurately mimicking in vivo conditions. Yung Lee, an undergraduate student in Dr. Charu Kaushic’s lab, recently published his first paper where he used an improved model to study the effects of female sex hormones on susceptibility to HSV-2 infection. Typically, a liquid-liquid interface (LLI) cell culture model, where both the apical and basolateral surfaces are submerged in growth medium, is used, however, this model is limited in its capacity to simulate physiological conditions. In the current study, immortalized vaginal cells were grown in an air-liquid interface (ALI), more closely simulating the in vivo conditions of the female reproductive tract. The vaginal cells grown in both LLI and ALI models were compared in regards to their growth, differentiation and susceptibility to HSV-2. Additionally, the effects of female sex hormones progesterone (P4) and estrogen (E2) were also examined. Lee et al. found that in comparison to LLI conditions, the ALI model induced cells to grow into multi-layers, which better resembles vaginal cells in vivo. They then used the ALI model to assess the effect of hormones and found that in the presence of P4, cells were more susceptible to HSV-2 infection. This is consistent with many studies showing that P4 can increase susceptibility to sexually transmitted infections. Overall, these results suggest an alternative model for studying host-pathogen interactions that is more physiological relevant to in vivo conditions of the female reproductive tract. Read more here.
Recently, Matthew Miller's group in collaboration with Dr. Caitlin Mullarkey and a PhD candidate, Wengqian He have looked at the critical role of epitope specificity in regulating cell mediated cytotoxicity against influenza A virus. In addition to neutralizing antigens, antibodies are also capable of stimulating cellular responses through Fc–Fc receptor interactions. The type of response stimulated by these interactions is influenced by both the Fc receptor type expressed on the effector cell and the isotype of antibody to which it is bound. However, how antibody specificity influences Fc receptor functions, and how antibodies of different specificities interact to modulate these functions, remain unknown. Using influenza A virus as a model, we demonstrate that antibody specificity profoundly influences the induction of antibody-dependent cell-mediated cytotoxicity by effector cells. In addition, we show that interactions among antibodies that bind to discrete epitopes on the same antigen can influence the induction of Fc-dependent effector functions. Read more here.
Congratulations to Matthew Miller for being awarded the 2015 - 2016 CIHR New Investigator Award!
Chronic cigarette smoke exposure is known to damage pulmonary lipids, resulting in innate inflammatory responses. Cigarette smoke is also known to activate the adaptive immune system, however, the role of these adaptive immune processes has yet to be fully understood. A study by Danya Thayaparan, a Masters student from Dr. Stampfli’s lab, reports a link between damaged lipids and the production of autoantibodies. Thayaparan et al. showed, using a mouse model, that chronic exposure to cigarette smoke led to the induction of antibodies against oxidized low-density lipoproteins (OxLDL). To examine the potential function of autoantibodies against OxLDL, they used a monoclonal antibody against oxidized phosphatidylcholine (OxPC), the most prevalent phospholipid in lung surfactant. Overall, they found that antibodies against OxPC do not exacerbate cigarette smoke-induced inflammation, and instead, promote lipid and particle uptake by pulmonary macrophages, even after smoking cessation. Altogether, this study suggests a protective function for autoantibodies induced by chronic cigarette smoke exposure. Read more here.
Exciting news coming from the Kaushic Lab, where post-doctoral fellow Dr. Jocelyn Wessels was recently awarded the prestigious Ontario Women’s Health Fellowship. The award, funded in 2001 by the Ontario Ministry of Health and Long-Term Care, recognizes a distinguished group of Ontario scholars who are working to improve women’s health through research focusing on issues such as contraception, breast cancer, and health during pregnancy. The award hopes to support scholars in their efforts to create new knowledge about women’s health, and to help develop more effective health services and products for women. MIRC member Dr. Wessels was one of only two post-doctoral fellows to receive the award, which includes a $50,000 fellowship and an additional $5000 for research. Her research focuses on how female sex hormones found in contraceptives affect vaginal health and susceptibility to sexually transmitted infections, such as HIV. Specially, Dr. Wessels’ research will investigate how Depo-Provera, a progestin-based contraceptive, affects healthy bacteria within the vaginal tract which protect against infections, and whether these changes make women more susceptible to HIV. Read more about the award here, and congratulations to Dr. Wessels!
Pulmonary tuberculosis (TB) caused by Mycobacterium Tuberculosis, is one of the leading causes of global morbidity and mortality, and one of the primary reasons for the deathly nature of this infection is the absence of an effective vaccine. Although there are numerous candidate TB vaccines being tested, the ability of these vaccines to improve protection by inducing clinically relevant protective T cell responses is largely unknown until the completion of expensive efficacy trails. As such, not only is there an urgent need to develop effective vaccination strategies, there is also a pressing need to develop alternative approaches to evaluate the protective potential of vaccine candidates. This can save a lot of valuable time and money. Interestingly, Dr. Zhou Xing’s lab has developed a systematic immunological approach to investigate the protective potential of a novel TB vaccine. In the newly published study directed by Dr. Mathy Jeyanathan, PBMC’s cryopreserved from healthy adults who had been vaccinated intramuscularly with a novel TB vaccine in a previous phase I study were used to screen for likely dominant T cell epitopes following vaccination. Next, Jeyanthan et al. expanded antigen-specific memory T cell lines to identify CD4 and CD8 memory T cell epitopes, and found that immunization with the vaccine in question resulted in the generation of a memory T cell repertoire capable of recognizing multiple epitopes. Furthermore, the epitope-specific memory T cells were polyfunctional and cytotoxic, and able to suppress mycobacterial growth in infected cells. Based on this approach, the study recommended that the candidate TB vaccine in question should undergo further development. Most importantly, Jeyanthan et al. have created an approach that can be incorporated into future early TB vaccine trails and can be used to greatly assist in TB vaccine development. Read more here.
Congratulations to PhD candidate David Hare from Dr. Karen Mossman’s lab, who was recently awarded the Medical Sciences Impact Award. The Impact Award acknowledges graduate students who have demonstrated excellence in research and whose work has been published in a highly meritorious first-authored scientific paper. It is presented to one student from each research stream in the Medical Sciences program on a yearly basis, and David Hare is this year’s winner from the Infection and Immunity stream. David recently published in the Journal of Virology, reporting on the role of cytosolic receptors and their ability to recognize genomes within incoming virus particles prior to virus replication. Congratulations David! Read More.
IL-33, known to play a role in both innate and adaptive immune responses, has been suggested to be involved in inflammatory lung disease, as IL-33 influences Th2-skewed immune functions in allergic responses. Evidently, elevated levels of IL-33 are found in mouse models of allergic airway disease and in chronic human lung conditions such as severe asthma. Similarly, the gp130 cytokine Oncostatin M (OSM) is also known to be elevated in cases of severe asthma. However, the link between OSM and IL-33 remained largely unknown until a recent study out of Dr. Carl Richard’s lab suggesting a novel OSM-IL-33 axis in lung tissue cells. Led by Dr. Fernando Botelho, the study provides evidence for a novel method of IL-33 regulation in murine lung epithelial cells mediated by OSM. Using an in vivo mouse model and cell-culture techniques, they found that transient overexpression of OSM resulted in significantly increased induction of IL-33 in the lung, specifically in alveolar epithelial cells. In addition, IL-33 induction was associated with the activation of STAT3 and inhibition of STAT3 reduced IL-33 levels, suggesting a role for STAT3 activation in OSM-mediated regulation of IL-33. This study demonstrates a new role for OSM as a potent inducer of IL-33 in mouse lung epithelial cells, suggesting an additional mechanism for IL-33 regulation in innate immunity and pulmonary pathology. Read more here.
The 2016 Faculty of Health Sciences (FHS) Research Plenary was held from May 17-19th and showcased the work of several MIRC students and postdoctoral fellows via oral and poster presentations. Several MIRC trainees were selected for special awards. The following students were awarded Excellence in Poster Presentations: Sara Dizzell, Anisha Dubey, Dessi Loukov and Danielle Vitali. In addition, Kyle Novakowski was awarded for Outstanding Oral Presentation.
Other awards were also presented at the reception, recognizing the excellent work and outstanding achievements of MIRC trainees.
Faculty of Health Sciences Graduate Programs Outstanding Achievement Award
Faculty of Health Science Graduate Programs Outstanding Thesis Awards
Faculty of Health Sciences Graduate Programs Outstanding Excellence Awards
2015-2016 External and Internal Award Holders
Kaushal Baid (Mitacs Globalink Graduate Fellowship)
Michael Dorrington (Canadian Lung Association)
Joanne Hammill (Canadian Breast Cancer Foundation doctoral award)
David Hare (NSERC PGS-D3)
Joshua Koenig (CIHR CGS-M)
Amanda Lee (CIHR Vanier)
Joshua McGrath (Firestone Institute for Respiratory Health Graduate Students Scholarship)
Aveshni Naidoo (CGS-D Banting)
Kyle Novakoswski (Ontario Graduate Scholarship)
Pat Schenck (CIHR CGSD)
Tarandeep Singh (Ontario Graduate Scholarship)
Netusha Thevaranjan (The Michael Kamin Hart Memorial Scholarship)
Congratulations to all of the MIRC award winners!
Join us today to watch our very own, Dr. Dawn Bowdish, as she gives a presentation on inflammation, infections and the immune system on September 10th starting at 8 pm in EAC. The presentation is sponsored by Hamilton Association for the Advancement of Literature, Science and Art.
HSV-2 is one of the most dominant sexually transmitted infection (STI) worldwide, with global estimates of approximately 530 million individuals who are positive for HSV-2. Rate of infection is higher in women, however, the cause for increased susceptibility has not been established. It has been shown that the hormonal microenvironment may be playing a role, as hormone treatment in animal models has shown to differentially prime immune responses to HSV-2. A recent study examining the role of estradiol in HSV-2 infection, led by MIRC graduate Varun Anipindi from Dr. Charu Kaushic’s lab, was published in PLoS Pathogens. The study showed, for the first time, a mechanism to describe how estradiol, a female sex hormone present during the menstrual cycle and found in oral contraceptives, can protect against sexually transmitted viral infections. Using a mouse model of HSV-2 infection, Anipindi and collegues showed that estradiol primes dendritic cells in the vaginal tract to induce a Th17 response, which coincides with an increase in anti-viral Th1 responses. This pathway has important implications for addressing if some hormonal contraceptives may be better than others for women who are at higher risk for acquiring STIs. In addition, “We hope this raises awareness about the importance of vaccines administered by the mucosal route, and how this strategy can induce better protection,” says lead author Dr. Varun Anipindi. The study was highlighted as the Featured Research Article by PLoS Pathogens, selected by the Editors-in-Chief as being “a high-quality research article that is of particular importance and relevance to the pathogens community and general public”. Congratulations to Dr. Varun Anipindi and Dr. Charu Kaushic! Read More.